Skip to main content
Innovative treatments for prostate cancer

Department(s) concerned

News

Movember

Innovative treatments for prostate cancer

The Caen Normandy University Hospital is committed to offering its patients privileged access to cutting-edge technologies for comprehensive and effective management of prostate cancers.

A regional pillar of excellence in men's health

The urology department boasts innovative technologies, including targeted imaging that enables highly precise biopsies. This approach allows for the effective detection of potentially aggressive cancers. Furthermore, thanks to joint funding from the Normandy Region and the Caen Normandy Health Foundation of the Caen Normandy University Hospital, the urology department's technical platform is equipped with a DaVinci surgical robot and a Koelis ultrasound scanner, enabling highly precise, minimally invasive surgical procedures.

With over 1,500 men treated annually, the Caen Normandy University Hospital actively serves western Normandy, working closely with surrounding hospitals to ensure access to quality care. In partnership with the Maurice Tubiana Center, the Caen Normandy University Hospital teams refer patients for radiotherapy sessions when necessary.

In parallel, the hospital's physicians are actively involved in medical research, resulting in the implementation of cutting-edge protocols. These research protocols offer patients access to the latest advances in imaging technologies and new medical approaches, with the aim of improving both the diagnosis and treatment of prostate cancer in nuclear medicine.

A revolutionary new treatment for metastatic prostate cancer

At Caen Normandy University Hospital, the nuclear medicine and theranostics department is revolutionizing the treatment of metastatic prostate cancer. Thanks to a special molecule, it is now possible to detect and target prostate cancer metastases with unprecedented precision, down to the cellular level. This medical advance is a true revolution, as it minimizes the side effects often associated with traditional treatments, thus significantly improving patients' quality of life. Furthermore, by directly targeting cancer cells, this innovative treatment increases the chances of survival for patients with metastatic prostate cancer.

In 2024, the first patients at the Caen Normandy University Hospital will benefit from this promising medical advance, marking a significant step in the fight against this disease.

Communications Department of the Caen Normandy University Hospital
Caen Normandy University Hospital

Press contact

Communications and Sponsorship Department,
Avenue de la Côte de Nacre,
CS 30001
, 14033 CAEN cedex 9